Data: 26,300 SOL transferred from one exchange to another, worth approximately $3.2768 million.

Keurig Dr Pepper Inc recently announced its long-term financial targets, projecting that by 2026, the company’s adjusted diluted earnings per share (EPS) will achieve low double-digit percentage growth on a constant currency basis.

Biopharmaceutical company Fulcrum Therapeutics recently disclosed that by the end of 2025, its total holdings of cash, cash equivalents, and marketable securities will reach $352.3 million.

Enviri Corporation recently disclosed that an audit revealed a historical accounting error related to a UK pension plan, which had been fully frozen decades ago.

Data released by Iovance Biotherapeutics, Inc. shows that its core therapy Lifileucel demonstrates a favorable safety profile.